Sinovac's COVID-19 shot is 83% effective, not 91%, Turkey says

ISTANBUL -- Researchers in Turkey on Wednesday reported an efficacy rate of 83.5% for the coronavirus vaccine developed by Chinese company Sinovac Biotech based on final Phase 3 clinical trial results there, down from 91.25% announced in late December from interim results.